CTOs on the Move

Innovatient Solutions

www.innovatient.com

 
Innovatient helps healthcare organizations deliver better care through an interactive patient experience and engagement technology platform. The highly customizable software provides an easy-to-use solution delivered via TV, tablet, or bedside monitor engaging patients during treatment and after they go home, fostering an environment of wellness and improved outcomes. Our integrated nurse rounding, communication, and patient education tools result in improved patient satisfaction scores (HCAHPS) transforming the patient experience creating long-term relationships with healthcare providers.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Fairview-University Medical Center

Fairview-University Medical Center is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kapiva

Kapiva.in is an Indian brand that offers a wide range of Ayurvedic products such as herbal teas, health supplements, ghee, honey, and more. Their products are made using natural, high-quality ingredients and are designed to promote holistic health and ...

Loomis House

Loomis House is a Holyoke, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elara

Elara Caring is one of the nation`s largest providers of home-based care, with a national footprint in the Northeast, Midwest and Southwest. Elara brings together three award-winning organizations – Great Lakes Caring, National Home Health Care, and Jordan Health Services – into one transformational company, which provides the highest-quality comprehensive care continuum of personal care, skilled home health, and hospice care. The company is comprised of 32,500 caregivers serving over 65,000 patients and their families daily, in 225 locations across 16 states and focused on providing our patients with the “right care, at the right time, in the right place.”

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.